Delivery Order SPE2DR25D1017-SPE2DR26F9DCM
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,764.80 to AmerisourceBergen Drug Corp for the supply of Rectiv 0.4% Ointment on January 7, 2026, with an ultimate completion date of February 4, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,613.32 to AmerisourceBergen Drug Corp for 30 grams of Rectiv 0.4% ointment, a topical medication. This non-set-aside, competitively awarded contract was executed on December 9, 2025, with an ultimate completion date of December 10, 2025, and operates under firm fixed pricing. The order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,219.76 to AmerisourceBergen Drug Corp for Rectiv 0.4% Ointment in a 30-gram quantity. The contract was competitively awarded without a set-aside designation and utilizes firm fixed pricing. This delivery order was completed on April 23, 2025, one day after the award date of April 22, 2025. The product will be performed and sourced from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,436.34 firm fixed-price delivery order is for Rectiv 0.4% Ointment, 30 grams. The contract has an ultimate completion date of April 30, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- The Defense Logistics Agency awarded a delivery order valued at $1,546.46 to AmerisourceBergen Drug Corp for Rectiv 0.4% Ointment (30 grams), with an ultimate completion date of December 24, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively to the prime contractor. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order for Rectiv 0.4% Ointment (30 grams) with a ceiling value of approximately $4.0K under a firm fixed-price contract. The award, dated November 25, 2025, with an ultimate completion date of November 26, 2025, represents a non-set-aside competitive award to the prime contractor. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $4,465.84 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Rectiv 0.4% Ointment in 30-gram units, with completion scheduled for August 20, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate...
- This delivery order, valued at $4,139.74, was awarded on September 24, 2025, to AmerisourceBergen Drug Corp for the supply of Rectiv 0.4% Ointment in 30-gram quantities. The contract is a firm fixed price delivery order with no set-aside designation, issued competitively by the Defense Logistics Agency (DLA), an agency within the Department of Defense. Performance of this order is based at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order valued at $15,698.77 to AmerisourceBergen Drug Corp for Rectiv 0.4% ointment on December 10, 2025, with an ultimate completion date of January 8, 2026. This firm fixed price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for Rectiv 0.4% Ointment in 30-gram units, with a firm fixed price ceiling value of $1,570.88 and an ultimate completion date of August 18, 2025. This competitively awarded, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9DCMDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,378.12 to AmerisourceBergen Drug Corp for the supply of Rectiv 0.4% Ointment in 30-gram units. This competitively awarded, firm fixed-price delivery order was issued on January 13, 2026, with an ultimate completion date of January 14, 2026. The contract involves no set-aside designation, allowing the award to be made through full and open competition. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the company's headquarters location. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor and critical federal medical procurement vendor serving military and veteran healthcare systems. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The DLA utilizes this contract vehicle to efficiently fulfill essential pharmaceutical needs across military treatment facilities and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 1/12/26 |